INTRODUCTION
Streptococcus (S.)pneumoniae is the most frequently isolated pathogen in communityacquired pneumonia (CAP) 1, 2 and an important causative organism in sepsis, especially in the context of pneumonia 3, 4 . As such, S. pneumoniae is a major source of morbidity and mortality 5, 6 .
Mast cells (MCs) are evolutionary preserved cells that have become increasingly appreciated as important modulators of the host immune response 7 . Particularly prominent at the host-environment interface they function as sentinels and can become activated by invading pathogens or inflammatory mediators 8 . MCs are equipped with preformed, readily active proteases stored in cytoplasmic granules that can be released upon activation. Their activation may modify the immune response by producing and releasing various cytokines in response to stimuli independent of degranulation 7 . MC derived proteases can affect the inflammatory process profoundly, by modifying the extracellular matrix, recruiting neutrophils and other immune cells to the site of infection, modulating the activation of these immune cells and enhancing bacterial killing after phagocytosis 9-11 . Moreover, MCs are known to produce antimicrobial peptides, known as cathelicidins 12, 13 . Indeed, MCs were crucial for clearance of Escherichia coli and Klebsiella (K.) pneumoniae from the peritoneal cavity as well as Mycoplasma pneumoniae and K. pneumoniae from the lung, ultimately influencing the outcome in these infection models 11, 14, 15 .
Knowledge of the role of MCs in host defense against S. pneumoniae is limited. A recent study demonstrated that primary human lung MCs exhibit direct antimicrobial activity towards S. pneumoniae in vitro; this investigation did not study the in vivo relevance of this finding 16 . We here sought to establish the role of MCs in the immune response to pneumococcal pneumonia.
MATERIALS AND METHODS
For more detailed Materials and Methods please see the supplementary material.
Patients
Expression of c-Kit and tryptase were determined on lung tissue slides from ten patients who had succumbed to CAP with positive sputum and/or blood cultures for S. pneumoniae and from eight patients who had died from a non-pulmonary cause (for details see the online data supplement).
Animals

MC-deficient Kit
W-sh/W-sh (B6.Cg-KitW-sh/HNihrJaeBsmJ) mice on a C57BL/6 genetic background were originally from the Jackson Laboratory (Bar Harbor, ME, USA) and bred at the animal care facility of the Academic Medical Center. Age and gender matched specific pathogen-free C57BL/6 mice were purchased from Charles River (Maastricht, The Netherlands) and were used at 10-12 weeks of age. 
Bacterial quantification
To assess bacterial loads, undiluted whole blood and serial t10-fold dilutions of organ homogenates, bronchoalveolar lavage fluid (BALF) and whole blood were made in sterile isotonic saline and plated onto sheep-blood agar plates. CFUs were counted after 16 hours of incubation at 37°C.
Assays
Levels of interleukin (IL)-6, tumor necrosis factor alpha (TNF-α,), macrophage-inflammatory protein (MIP)-2, keratinocyte-derived cytokine (KC), lipopolysaccharide-induced CXC chemokine (LIX), IL-1β (all R&D Systems, Abingdon, UK) and myeloperoxidase (MPO; HyCult Biotechnology, Uden, The Netherlands) were measured using commercially available ELISA kits. The cytometric beads array multiplex assay (BD Biosciences, San Jose, CA) was used to measure TNF-α and IL-6 in plasma, as well as monocyte chemotactic protein (MCP)-1 and interferon-gamma (IFN-γ) in lung homogenates and plasma.
Histopathology
Paraffin-embedded 4-µm lung sections were stained with hematoxylin and eosin (H&E), analyzed for inflammation and tissue damage, and semiquantitatively scored by a pathologist as described previously 20 .
Immunohistochemistry
Neutrophil stainings on mouse lung tissue were performed using fluorescein isothyiocyanate-labeled rat anti-mouse Ly-6 monoclonal antibody (Pharmingen, San Diego, CA) and analyzed as described previously 20, 21 .
Statistical analysis
Data are expressed as indicated. Differences between groups were analyzed by MannWhitney U tests or paired t test when appropriate. Survival curves were compared using the log-rank test. All analyses were done using GraphPad Prism (GraphPad Software, San Diego, CA, USA). A P value of < 0.05 was considered statistically significant.
RESULTS
Expression of MCs and tryptase in human lung tissue during CAP
To obtain insight into the (co-) expression of MCs and tryptase in the context of CAP caused by S. pneumoniae we performed a MC (c-Kit) and tryptase double-staining on lung tissue of patients who had died from pneumococcal pneumonia or (control) patients who had died from a non-pulmonary cause. MCs and tryptase mainly colocalized in human lung tissue samples (Supplementary Figure 1) . The total number of c-Kit/ tryptase double positive cells was similar in lungs from control patients and unaffected lungs from CAP patients (Supplementary Figure 1A) . However, the number of c-Kit/ tryptase positive cells, and number of total MCs were lower in tissue of affected lungs of CAP patients (Supplementary Figure 1B) . Representative slides of control patients, unaffected and affected lung of CAP patients are shown in Supplementary Figure 1C- hours after infection compared with WT mice (P< .05) and a trend toward overall better outcome (P=.10, Figure 1B ).
Impact of MCs on bacterial growth depends on the phase of pneumococcal pneumonia
We wondered whether MCs influence growth of S. pneumoniae in the host and quantified bacterial loads at predefined time points in BALF, lung homogenates, blood and spleen homogenates (Figure 2A-D 
Impact of MC deficiency on lung inflammation
We determined the extent of inflammation in lung tissue slides from Kit W-sh/W-sh and WT mice during the course of infection, significantly so at 48 hours ( Figure 4 ). Next, we measured the levels of chemokines (KC, MIP-2, MCP-1) and proinflammatory cytokines (TNF-α, IL-1β, IL-6, IFN-γ) in BALF and whole lung homogenates harvested at 3, 6 (data not shown), 24 and 48 hours after infection (Table 1) . At 3, 6 and 48 hours the pulmonary concentrations of all mediators measured were similar in both mouse strains (with the exception of MCP-1 at 48 hours). Remarkably, nearly all of these inflammatory mediators were lower in lung homogenates of Kit 
MC stabilizing agents doxantrazol and cromoglycate do not influence the host immune response in S. pneumoniae pneumonia
MCs have many preformed inflammatory mediators stored in their granules that can alter the host inflammatory response upon degranulation 24 . Therefore, we examined the effect of two MC stabilizing agents, doxantrazol and cromoglycate, using dosing regimens previously shown to affect MC responses in rodents in vivo 25, 26 . For these studies we focused on late stage pneumonia by considering the strong phenotype of Kit W-sh/W-sh mice at 48 hours after infection. Neither doxantrazol (Supplementary Figure 2) nor cromoglycate (Supplementary Figure 3) influenced bacterial loads nor did these compounds influence lung or plasma concentrations of cytokines or chemokines (data not shown).
Impact of MCs on bacterial loads after infection with serotype 2 wild-type and pneumolysin deficient S. pneumoniae
Pneumolysin is important for activation of MCs to induce antimicrobial activity toward S. pneumoniae 16 . We studied bacterial loads in Kit ) mice. Data are expressed as mean ± standard error of the mean of n = 8 per group. Abbreviations: IL, interleukin; IFN, interferon; TNF, tumor necrosis factor; KC, keratinocyte-derived cytokine; LIX, lipopolysaccharide-induced CXC chemokine; MCP-1, monocyte chemotactic protein-1; MIP-2, Macrophage-inflammatory protein-2. * P < .05, ** P < .01 and *** P < .001 compared with WT. Figure 5 , left panels), whereas bacterial numbers after infection with D39Δply were much lower in Kit W-sh/W-sh than in WT mice ( Figure 5 , right panels).
DISCUSSION
MCs have recently gained more recognition as important effector cells during infection, capable of affecting both immediate innate processes and delayed adaptive immune responses, raising the possibility to modulate the course of an infection. In previous experimental infection studies, MCs predominantly favored bacterial clearance, resulting in decreased lethality 11, 14, 15, [27] [28] [29] . Our current findings, on the contrary, suggest that MCs have a detrimental effect on bacterial growth and dissemination during pneumococcal pneumonia and that this effect is mediated independent of degranulation. In a small case series of human lung tissue obtained postmortem from patients who had died from pneumococcal pneumonia in the lung affected by pneumonia, the number of c-Kit/tryptase positive cells was reduced relative to unaffected lung tissue, suggesting that MCs are not recruited to the site of infection during human respiratory tract infection. Rather, these findings indicate that MCs are resident in lung tissue 30 , where they may rapidly respond to invading pathogens. To study the functional role of MCs we infected MC deficient and WT mice with viable S. pneumoniae via the airway. Remarkably, in the early phase (<6 hours) of infection, we revealed a bimodal role of MCs regarding bacterial growth in the pulmonary compartment, which was confirmed in an independent experiment. Three hours post infection bacterial counts were higher in lungs of WT than in lungs of Kit W-sh/W-sh mice, whereas the opposite was true at 6 hours. Pulmonary neutrophil numbers and activity did not differ between study groups at 3 hours post infection, while at 6 hours WT mice displayed lower neutrophil activity compared to Kit Important prestored mediators of MCs include TNF-α and IL-6, which can be released within the first minutes after stimulation. However, in the early phase (<6 hours) of infection, WT mice did not exhibit higher levels of TNF-α or IL-6 in BALF or lungs relative to Kit W-sh/W-sh mice. Accordingly, in previous studies, live pneumococci stimulated degranulation of MCs without the release of prestored TNF-α or de novo synthesis of TNF-α and IL-6 33 . Moreover, no differences were observed in any measured cytokines/chemokine between strains, suggesting that MC deficiency does not have a pronounced impact on early inflammatory mediator production in the lungs during pneumococcal pneumonia. In the later phase of infection (beyond 6 hours) the presence of MCs was associated with increased bacterial counts in lungs and systemic dissemination. Although a clear mechanistic explanation is lacking at present, these data are in accordance with the delayed mortality of Kit defense of these mice after infection with serotype 3 pneumococci (6303). The results obtained with S. pneumoniae 6303 suggest that if direct antimicrobial activity of MCs contributes to host defense during pneumococcal pneumonia it is only detectable very early after infection (i.e. 6 hours after infection). These results suggest that the role of MCs in host defense during pneumococcal pneumonia at least in part depends on the composition of the capsule and cell wall, and that the antimicrobial activity of MCs toward pneumococci does not contribute to the eventual growth of this pathogen in the lower airways after infection with either a serotype 2 (D39 and D39Δply) or 3 (6303). MCs are known to release (preformed) mediators from their granules, which have the ability to both promote and dampen an inflammatory reaction 24 . We wondered whether the observed phenotype was dependent on MC degranulation. In vitro, live pneumococci induced MC degranulation in a dose-and time-dependent manner 33 .
Moreover, stimulation of MCs through TLR2 by peptidoglycan, a component of the cell wall of Gram-positive bacteria, induced both degranulation and cytokine production 40 .
Important prestored mediators of MCs are IL-6, TNF-α and tryptase. As described above, the first two mediators were not released by live pneumococci in vitro and IL-6 and TNF-α were not different between Kit W-sh/W-sh and WT mice in the early stage of our in vivo model, arguing against a role for these two cytokines in the phenotype of MC-deficient mice during pneumococcal pneumonia described here. MC-restricted tryptase mMCP-6 can have an immune protective role in bacterial infections 29 and is able to mediate neutrophil extravasation 9 . Recombinant tryptase instilled into lungs of mice increased neutrophil numbers more than 100-fold 41 . However, we could not detect tryptase activity in BALF of WT mice infected with pneumococci, and administration of the tryptase-specific inhibitor nafamostat 42 did not have an impact on bacterial growth or dissemination (data not shown), suggesting that tryptase does not play a major role in our model of pneumococcal pneumonia. To test whether other mediators released from MCs upon degranulation are of more functional importance, we inhibited MC degranulation using two MC stabilizers. However, neither doxantrazol nor cromoglycate influenced bacterial growth or the inflammatory response in lungs or plasma of mice during pneumococcal pneumonia.
In conclusion, we report an unfavorable effect of MCs for the host on bacterial multiplication and dissemination during respiratory tract infection by S. pneumoniae, which results in accelerated death independently of MC degranulation. These data suggest that the pneumococcus has evolved strategies to misuse MCs in the airways in order to cause invasive infection.
SUPPLEMENTARY MATERIAL MATERIALS AND METHODS
Patients
Paraffin-embedded lung tissue, stored in in the Department of Pathology, Academic Medical Center, Amsterdam, was used from ten patients (mean age 69 ± 6 yrs) who had succumbed to CAP with positive sputum and/or blood cultures for S. pneumoniae and from eight patients (mean age 62 ± 9 yrs) who had died from a non-pulmonary cause, according to the 'Code for Proper Secondary Use of Human Tissue' , Dutch Federation of Medical Scientific Societies. Expression of c-Kit and tryptase were determined on lung tissue slides (for details on the procedure see the online data supplement); in CAP patients both the lung with histologic signs of pneumonia ("affected side") and the contralateral lung ("unaffected" side) were analyzed.
c-Kit and tryptase double-staining
Paraffin-embedded lung tissue derived from patients with pneumococcal pneumonia and controls were retrieved from the archives of the Department of Pathology, Academic Medical Center, Amsterdam. Ten patients (mean age 69 ± 6 years) who had succumbed to CAP with positive sputum and/or blood cultures for S. pneumoniae and eight patients (mean age 62 ± 9 years) who had died from a non-pulmonary cause were included in this study. According to Dutch law, these samples can be freely used after anonymizing the tissues, provided these are handled according to national ethical guidelines ('Code for Proper Secondary Use of Human Tissue' , Dutch Federation of Medical Scientific Societies). To determine MC and tryptase expression in the human lung in the context of CAP, expression of c-Kit and tryptase were determined on lung tissue slides. In brief, 5-μm human lung sections were first deparaffinized and rehydrated. After washing with running tap water, a non-serum protein block was applied for 15 min at room temperature (Ultra V Block; Thermo Scientific/LabVision). A heat-induced antigen retrieval procedure using Tris-EDTA at pH 9.0 for 20 min was performed on all tissue sections, which were subsequently incubated with a 1:500 dilution rabbit-anti-human c-Kit (CD117 clone A4502, DAKO, Carpinteira, CA) overnight at 4 °C, followed by incubation with biotinylated goat anti-rabbit poly alkaline phosphatase (AP) (DPVR-110AP, ImmunoLogic, Duiven, The Netherlands). Visualization of antibody reactivity was performed with Vector Blue (Brunschwig Chemie, Amsterdam, the Netherlands) as chromogen. To remove the antibodies from the first staining sequence, but leaving the deposits of blue reaction 
